Immune-engineered device targets chemo-resistant lymphoma

Immune-engineered device targets chemo-resistant lymphoma 04/17/2018 12:50 PM EDT Cornell University researchers have developed a "lymphoma micro-reactor" device that exposes human lymphomas to fluid flow similar to that in the lymphatics and parts of the lymph node. It is designed to explore how fluid forces may relate to a tumors' drug resistance. Full story at http://news.cornell.edu/stories/2018/04/immune-engineered-device-targets-chemo-resistant-lymphoma Source Cornell University This is an NSF News From the Field item. Follow NSF:  This email was sent using GovDelivery Communications Cloud on behalf of: National Science Foundation Update · 2415 Eisenhower Avenue, Alexandria, VA 22314 · 703-292-5111